Pathology of pulmonary hypertension Dr.Ashraf Abdelfatah Deyab Assisstant Professor of Pathology Faculty of Medicine Almajma’ah University.

Slides:



Advertisements
Similar presentations
Pulmonary Hypertension
Advertisements

Respiratory Path III Dr Rotimi Adigun
Right Ventricular Failure (RVF) Occurs when the right ventricle fails as an effective forward pump, causing back-pressure of blood into the systemic.
Chronic obstructive pulmonary diseases (COPD)
AM Report Lauren Galpin, MD MA  “Thromboembolic obstruction of the major pulmonary arteries due to unresolved pulmonary embolism [with pulmonary.
CHEST X-RAY FINDINGS: Left-to-Right Shunt
Atrial and Ventricular Enlargement
Heart Pathology Department, Zhejiang University School of Medicine, Zhu keqing 竺可青,
Pulmonary Vascular Disease. Pulmonary Circulatuion Dual supply  Pulmonary arteries  Bronchial arteries Low pressure system Pulmonary artery receives.
Vascular Diseases of Lungs. Pulmonary Hypertension It is the increase in blood pressure in pulmonary arteries, veins and capillaries. It leads to shortness.
Hemodynamic Tutorial.
Chapter: 38 Pulmonary Circulation, Pulmonary Edema, Pleural Fluid
Pulmonary Hypertension and Various Treatment Options
1.Pulmonary Vascular Disease 2.Pleural Disease Prof. Frank Carey.
Embolism.
Management of Patients With Chronic Pulmonary Disease.
Pathology of chronic obstructive airway diseases
HEART FAILURE PROF. DR. MUHAMMAD AKBAR CHAUDHRY M.R.C.P.(U.K) F.R.C.P.(E) F.R.C.P.(LONDON) F.A.C.C. DESIGNED AT A.V. DEPTT F.J.M.C. BY RABIA KAZMI.
Pathology of Pulmonary Hypertension Wolter J. Mooi Department of Pathology, VUmc Amsterdam
Respiratory Tutorial. Pulmonary oedema Causes –Haemodynamic Increased hydrostatic pressure –(heart failure, mitral stenosis, volume overload) Decreased.
Hemodynamic Disorders (Disorders of blood flow)
Congestion.
بسم الله الرحمن الرحيم Prepared by: Ala ’ Qa ’ dan Supervisor :mis mahdia alkaunee Cor pulmonale.
GAS EXCHANGE (Lecture 5). The ultimate aim of breathing is to provide a continuous supply of fresh O2 by the blood and to constantly remove CO2 from the.
THROMBOSIS Dr. Afsar Saeed Shaikh M.B.B.S, M.Phil. Assistant Professor of Chemical Pathology Pathology Department, KEMU, Lahore.
Formation of the Heart and Heart Defects Michele Kondracki
Vanessa Beretta & Dan Fleming. About CHD A congenital heart defect also known as CHD is a defect in the structure of the heart and great vessels. Most.
Ischaemic Heart Disease. Aims and Objectives n Ischaemic heart disease –Definition, manifestations, epidemiology, aetiology, pathophysiology, risk factors.
Katie DePlatchett M.D. AM Report June 29,  Elevated Pulmonary Artery pressure  Secondary R Ventricular failure  Mean Pulm Artery Pressure of.
1 Benign Nephrosclerosis Definition: renal changes in benign hypertension It is always associated with hyaline arteriolosclerosis. mild benign nephrosclerosis.
5/98MedSlides.com1 Pulmonary (Arterial) Hypertension
Atherosclerosis CVS lecture 2 Atherosclerosis Shaesta Naseem.
Respiratory failure Respiratory failure is a pathological process in which the external respiratory dysfunction leads to an abnormal decrease of arterial.
Atherosclerosis CVS 1 Hisham Al Khalidi. Atherosclerosis.wmv.
万用卡 The Pathophysiology of Respiratory Failure Department of pathophysiology Jianzhong Sheng MD PhD.
What Causes Cor Pulmonale?
פרופ ' נוויל ברקמן מכון הריאה ביה " ח האוניברסיטאי הדסה עין - כרם PULMONARY HYPERTENSION AND COR PULMONALE פרופ ' נוויל ברקמן מכון הריאה ביה " ח האוניברסיטאי.
CHRONIC PULMONARY EMPHYSEMA Airway obstruction disease Extensive alveolar destruction Trapping of excess air in lungs Obstruction Destruction Etiological.
Restrictive Lung Diseases. 1. Adult respiratory distress syndrome 2. Sarcoidosis 3. Asbestosis 4. Neonatal respiratory distress syndrome 5. Idiopathic.
Chapter 9 Heart. Review of Structure and Function The heart is divided into the systemic (left) and pulmonary (right) systems –The pulmonary system has.
Differentiate Pulmonary arterial hypertension from pulmonary venous congestion.
Haissam A Haddad, MD, FRCPC, FACC University of Ottawa Heart Institute
Faculty of allied medical sciences
Development of Lung Seoul National University Hospital
Cor Pulmonale Dr. Meg-angela Christi Amores. Definition Cor Pulmonale – pulmonary heart disease – dilation and hypertrophy of the right ventricle (RV)
Lecture II Congenital Heart Diseases Dr. Aya M. Serry 2015/2016.
Management of Patients With Chronic Pulmonary Disease
Cardiopulmonary Disorders. Common Cardiac Disorders Coronary Artery Disease Myocardial Infarction (MI) Heart Murmurs/Valvular Heart Disease Congestive.
Cardiovascular Pathology
R1 정수웅.  Idiopathic pulmonary fibrosis (IPF) is a specific form of chronic, progressive, fibrosing interstitial pneumonia of unknown cause that occurs.
Cardiac Pathology 3: Valvular Heart Disease, Cardiomyopathies and Other Stuff Kristine Krafts, M.D.
Cardio-vascular system Cardio-vascular system Dr Pedro Amarante Andrade.
Pulmonary Tumor Thrombotic Microangiopathy R3 김형오.
March Ch. 12 p (459 – 512 PULMONARY DISEASES OF VASCULAR ORIGIN.
1 COPD (Definitions + Pathology) Dr.Mohsen SHAHEEN Pneumologist Dr.Mohsen SHAHEEN Pneumologist.
Venous Thromboembolism-1
Human Physiology Respiratory System
HYPERTENSIVE HEART DISEASE (Hypertensive cardiomyopathy)
Diseases of the respiratory system lecture 5
Diseases of the respiratory system lecture 3
Table 21.4 Comparison of Gas Partial Pressures and Approximate Percentages in the Atmosphere and in the Alveoli © 2014 Pearson Education, Inc.
Left Ventricular Dysfunction With Pulmonary Hypertension
Lung diseases of Vascular Origin
H M M IF Causes of Pulmonary Hypertension in Patients with Sarcoid Perivascular fibrosis Increased vasoreactivity Granulomas in pulmonary.
Pulmonary diseases of vascular origin
Atelectasis, acute respiratory distress syndrome & pulmonary edema
Section 4: Plaque dynamics and stenosis
Pulmonary Hypertension (PH)
The impact of training on lifestyle diseases
Presentation transcript:

Pathology of pulmonary hypertension Dr.Ashraf Abdelfatah Deyab Assisstant Professor of Pathology Faculty of Medicine Almajma’ah University

Pathology of pulmonary vascular disease ► Damage to the vessels wall: ► - Arteritis with ischaemia and local necrosis (Wegener's granulomatosis, Churg-Strauss syndrome) ► - Good pasture's syndrome (with circulating anti- glomerular basement membrane antibody). ► Obstruction: Thrombo-embolism. ► Variation in intra-vsacular pressure: Arterial or venous hypertension.

Goals Pathology of Pulmonary hypertension Goals Pathology of Pulmonary hypertension ► Pathogenesis. ► Morphology ► Clinical features

Pulmonary hypertension - PH Introduction ► The pulmonary circulation is normally one of low resistance. ► Pulmonary BP is normally only about one eighth = (1\8) of systemic BP. ► Pulmonary hypertension (PH) defined when mean pulmonary artery pressure reaches one fourth= (1\4) of systemic levels or greater than BP> 25 mm Hg at rest & greater > 30 mm Hg during exercise.

Pulmonary hypertension – PH how common? Pulmonary hypertension – PH how common? to 600 cases diagnosed annually to 600 cases diagnosed annually. - Occur in men, women and children of all ages, However most common in women (20-40ys). - Occur in men, women and children of all ages, However most common in women (20-40ys). - Rare in children but sometimes seen in - Rare in children but sometimes seen in infants born with heart defect infants born with heart defect

What’s the main causes of increase pulmonary vascular pressure? The pressure within the pulmonary arterial system may be increased for two reasons: ► 1) Increased blood flow ► 2) Increased resistance within the pulmonary circulation.

Pulmonary hypertension – PH (Etiology) ► Can be classified into three main causes: ► 1- Secondary pulmonary hypertension. ► 2- Primary pulmonary hypertension. ► 3- Idiopathic.

Pulmonary hypertension – PH (Etiology) I) Secondary pulmonary hypertension: Secondary to another medical problem e.g: Secondary to another medical problem e.g: Diseases that impedes flow of blood through Lungs or Diseases that impedes flow of blood through Lungs or Diseases that affect the oxygen levels (periods of low oxygen) in blood. Diseases that affect the oxygen levels (periods of low oxygen) in blood. Examples: COPD, Scleroderma, pulmonary fibrosis, lung diseases such as asbestosis Examples: COPD, Scleroderma, pulmonary fibrosis, lung diseases such as asbestosis

Pulmonary hypertension – PH (Etiology) ► Secondary pulmonary hypertension main causes: 1) Cardiac diseases\causes. 2) Recurrent thrombo-embolism. 3) Inflammatory vascular disease. 4) Connective tissue disease 5) Lung diseases

Pulmonary hypertension – PH (Etiology) ► Secondary pulmonary hypertension: 1) Cardiac diseases: Congenital or acquired heart disease: - MI- increase left atrial pressure. - MI- increase left atrial pressure. - Left to right shunts e.g. septal defects. - Left to right shunts e.g. septal defects. - Mechanical obstruction e.g. atrial myxoma and mitral stenosis. - Mechanical obstruction e.g. atrial myxoma and mitral stenosis.

Pulmonary hypertension – PH (Etiology) 2) Recurrent thromboemboli: reduced vascular bed- increase vascular resistant. 3) Inflammatory vascular diseases: - scleroderma,other CT diseases & vasculitis. - scleroderma,other CT diseases & vasculitis. 4) Lung & Connective tissue diseases: COBD or interstitial, restrictive lung: hypoxia, alveolar and vascular bed damage- increase resistance- increase PH. COBD or interstitial, restrictive lung: hypoxia, alveolar and vascular bed damage- increase resistance- increase PH. - Pneumoconiosis e.g. asbestosis & silicosis. - Pneumoconiosis e.g. asbestosis & silicosis.

Pulmonary hypertension – PH (Etiology) 2- Primary pulmonary hypertension (Familial) - Rare, autosomal dominant. - Mutations in signaling pathway (BMPR2). - Mutations in signaling pathway (BMPR2). - No underlying cause for the high BP in lungs - No underlying cause for the high BP in lungs - Due to spasm of the muscle layer in pulmonary arteries, patients are sensitive to vasoconstrictors elements. - Due to spasm of the muscle layer in pulmonary arteries, patients are sensitive to vasoconstrictors elements. ► 3) Idiopathic PH: Sporadic, requires exclusion of other known causes. ► Usually women years old, some children.

Abnormally high BP in pulmonary vessels arteries Increased pressure damages large and small pulmonary arteries Blood vessel walls thicken Cannot transfer oxygen and carbon dioxide normally Levels of oxygen in blood fall Constriction of pulmonary arteries Further increase in pressure in pulmonary circulation

Pulmonary Hypertension right side of heart must work harderpush blood through pulmonary arteries to lungs right ventricle thickens and enlarges cor pulmonale Heart Failure In some people, the bone marrow will produce more red blood cells to compensate for less of oxygen in blood leading Polycythemia Extra RBCs cause the blood to become thicker and stickier, further increasing the load on the heart Pulmonary Embolism

PH- Pathogenesis ► I. Molecular basis (Mutation). (Primary PH). (Primary PH). ► II. Shear and mechanical injury (Secondary PH) (Secondary PH) ► III. Pulmonary vasoconstriction (Secondary PH) (Secondary PH) ► IV. Idiopathic

PH pathogenesis- Primary PH ► I. Molecular basis (Mutation): (Familial or primary PH) is caused by mutations in the bone morphogenetic protein receptor type 2 (BMPR2) signaling (with existence and support of modifier genes and/or environmental triggers), lead to: (Familial or primary PH) is caused by mutations in the bone morphogenetic protein receptor type 2 (BMPR2) signaling (with existence and support of modifier genes and/or environmental triggers), lead to: Pulmonary vascular thickening& occlusion : proliferation of endothelial, smooth muscle, and intimal cells accompanied by concentric laminar intimal fibrosis. Pulmonary vascular thickening& occlusion : proliferation of endothelial, smooth muscle, and intimal cells accompanied by concentric laminar intimal fibrosis.

PH& BMPR2 mutation ► BMPR2 is a cell surface protein belonging to the TGF-β receptor ► BMPR2 specific effects in vascular smooth muscle cells causes inhibition of proliferation & favors apoptosis. ► BMPR2 Mutation lead to increased smooth muscle survival and proliferation may be expected. ► BMPR2 plays it’s effect by support of gene modifier& environmental trigger.

yyy

PH pathogenesis- Secondary PH (II) Increased shear and mechanical injury (Secondary PH) produced endothelial cell dysfunction e.g.:: - Left to-right shunts (Mechanical). - Left to-right shunts (Mechanical). - Thromboembolism, injury mediated by biochemical injury produced by fibrin. - Thromboembolism, injury mediated by biochemical injury produced by fibrin.

Pulmonary Hypertension 1. Pulmonary Arterial Hypertension 2. Left Heart Disease 3. Chronic Hypoxemia 4. 4.Thromboembolic 5. Miscelaneous -Sarcoid, fibrosing mediastinitis

PH pathogenesis-Secondary PH III) Pulmonary vasoconstriction: III) Pulmonary vasoconstriction: Decreased elaboration of prostacyclin& nitric oxide-and increased release of endothelin- this lead to activate platelet Aggregation& adhesion. Decreased elaboration of prostacyclin& nitric oxide-and increased release of endothelin- this lead to activate platelet Aggregation& adhesion. * Endothelial activation, makes endothelial cells thrombogenic and promotes the persistence of fibrin.

PH pathogenesis-Secondary PH 3) Production and release of growth factors and cytokines induce the migration and replication of vascular smooth muscle cells and elaboration of extracellular matrix. 4) Vasospastic component, after ingestion of certain plants or medicines.

PH morphology ► Atheromas, Atheromatous deposits of pulmonary artery, branches. ► Medial hypertrophy =muscular thickness of muscular and elastic arteries. ► Initimal fibrosis= narrowing of the lumen, ► Organizing or recanalized thrombi, with coexistence of diffuse pulmonary fibrosis this favors recurrence.

Morphology of PH-Gross changes Pulmonary hypertension, reveal atheroma formation, usually limited to large vessels

Small peripheral pulmonary artery thromboembolus &their direct role in PH

Vascular changes in pulmonary hypertension ► Marked medial hyperatrophy ► Alveolar haemorrhages

(PH) morphology - Plexiform lesion caused by: - Plexiform lesion caused by: - Longstanding severe primary PH and idiopathic& CHD with left-to-right shift. - Longstanding severe primary PH and idiopathic& CHD with left-to-right shift. - Characterized by multi-channeled out- pouching of the arterial wall due to reparative lesions in areas of fibrinoid necrosis. - Characterized by multi-channeled out- pouching of the arterial wall due to reparative lesions in areas of fibrinoid necrosis.

Plexiform lesion- Pulmonary hypertension

PH morphology Coexistence morphological features: ► Diffuse pulmonary fibrosis, or severe emphysema and chronic bronchitis. ► Dilated vessels and arteritis may also be present. ► Extensive occlusion of the veins by fibrous tissue.

PH Clinical features Signs & symptoms ► Like other forms of HTN are subtle in the early stages. ► Sign& symptoms are hidden by underlying diseases, and varying from pt. to pt.  Initial Symptoms: dyspnea, fatigue, chest angina-like pain, cough, fail to put on wei ght like a normal child with slowed growth (in child) ► Overtime Severe respiratory distress, cyanosis, and right ventricular hypertrophy.

PH outcome ► Diagnosis: ► Proper medical work-up& correlation, rule- out others, Echo, lung FT, Lung scan, ect.. ► PH outcome: Death from decompensated cor pulmonale, often with superimposed thromboembolism and pneumonia, usually ensues within 2 to 5 years in 80% of patients. Death from decompensated cor pulmonale, often with superimposed thromboembolism and pneumonia, usually ensues within 2 to 5 years in 80% of patients.

THE END